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DObjectives: There are limited data defining the risk of repeat sternotomy for surgical aortic valve replacement in
octogenarian patients with aortic valve stenosis and previous coronary artery bypass graft operation. Our study
assesses the risk of operation.
Methods:We conducted a retrospective review of 629 octogenarian patients with aortic stenosis who received
isolated surgical aortic valve replacement between January 1993 and December 2011. Patient characteristics
included age 83.7  3.2 years, male sex in 322 patients (51.2%), and Society of Thoracic Surgeons predicted
risk of mortality of 6.2%  4.4%. Operations included a primary sternotomy in 518 patients (82.4%) and a
repeat sternotomy in 111 patients (17.6%) who had previous coronary artery bypass graft operation.
Patients with other cardiac operations were excluded from the study.
Results: Cardiopulmonary bypass time was longer with repeat sternotomy (88.0  45.7 minutes) in
comparison to primary sternotomy (66.5 25.1; P<.001); but there was no difference in the aortic crossclamp
time (51.1  19.7 minutes vs 49.2  17.7 minutes; P ¼ .282). Stroke occurred in 3 patients (2.7%) following
repeat sternotomy and in 10 (1.9%) after primary sternotomy (P ¼ .710). Rates of myocardial infarction,
renal failure, and reoperation for bleeding were similar between the 2 groups. Operative mortality occurred
in 7 patients (6.4%) after repeat sternotomy and in 19 patients (3.7%) following primary sternotomy
(P ¼ .196). Repeat sternotomy was not predictive of operative mortality.
Conclusions: Repeat sternotomy and surgical aortic valve replacement can be done with low risk in
octogenarian patients with previous coronary artery bypass graft operation. (J Thorac Cardiovasc Surg
2014;148:1899-902)Surgical aortic valve replacement improves symptoms
and prolongs survival with low operative morbidity and
mortality rates in most series of patients.1,2 In general,
repeat sternotomy does not increase the risk of operation.3
There are limited data on repeat sternotomy for surgical
aortic valve replacement in octogenarian patients, with
some series reporting an operative mortality of around
20%.4,5 But no study has looked specifically at the
outcome in octogenarian patients with previous coronary
artery bypass graft operation. Unfortunately, such patients
may be denied operation, or offered alternative therapy
(ie, transcatheter aortic valve replacement), based on
a perception of prohibitive risk of operative morbidity
and/or mortality associated with surgical replacement.e Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
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The Journal of Thoracic and CarThe objective of our study was to define the risk of
repeat sternotomy for surgical aortic valve replacement in
octogenarian patients with previous coronary artery
bypass graft operation.METHODS
This study was approved by the Mayo Clinic Institutional Review
Board. We reviewed the records of 1745 octogenarian patients who
received aortic valve replacement for aortic valve stenosis between January
1993 and December 2011. We excluded from study patients with a history
of previous noncoronary artery bypass graft cardiac operation (eg, valve
replacement or pericardiectomy) or infective endocarditis. In addition,
we excluded patients who received planned concomitant coronary artery
bypass graft operation, transcatheter aortic valve replacement, or other
nonaortic valve-related operation (eg, mitral or tricuspid valve operation
or pericardiectomy). We included in the study patients who received an
aortic root patch or enlargement procedure.
We identified an intent-to-treat cohort of 637 octogenarian patients who
met our inclusion and exclusion criteria. Of this group, 8 patients refused
research authorization; theywere subsequently excluded from further study.
That left 629 octogenarian patients for study.We formed 2 study groups that
included 518 patients (82.4%) who received primary sternotomy
(primary sternotomy group) and 111 patients (17.6%) who received repeat
sternotomy (repeat sternotomy group). All patients in the repeat sternotomy
group had undergone previous coronary artery bypass graft operation.
All operations were performed at Mayo Clinic, Rochester, Minn.
The Division of Cardiovascular Surgery database and individual patient
medical records were reviewed for data on patient characteristics anddiovascular Surgery c Volume 148, Number 5 1899
Abbreviation and Acronym
STS ¼ Society for Thoracic Surgeons
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Doperative intervention, morbidity, and mortality. Data on these variables
were collected in keeping with the standard definitions set forth by the
Society of Thoracic Surgeons (STS) as part of the National Adult Cardiac
Surgery Database. Operative mortality was defined as death occurring
within 30 days of operation or at any time during the index hospitalization.
Descriptive statistics for categorical variables are reported as frequency
(percentage) whereas continuous variables are reported asmean standard
deviation or median (range) as appropriate. Categorical variables were
compared using c2 or Fisher exact test and continuous variables using
2-sample t test or Wilcoxon rank-sum test where appropriate. Logistic
regression models were used to find the univariate and multivariate
predictors of operative mortality. The multivariable model considered
univariate significant variables (P< .05) with model selection using the
stepwise method. All statistical tests were 2 sided.RESULTS
Patient characteristics included a mean age of 83.7 3.2
years, male sex in 322 patients (51.2%), and an STS
predicted risk of mortality of 6.2%  4.4%. Operation
occurred during the second half of the study period in 86
patients (78.2%) in the repeat sternotomy group and in
357 patients (67.6%) in the primary sternotomy group
(P ¼ .065). Patient characteristics of the 2 study groups
are detailed in Table 1.
All patients received surgical aortic valve replacement.
Operations included an aortic root enlargement in 5 patients
(4.6%) in the repeat sternotomy group and in 36 patients
(6.8%) in the primary sternotomy group (P ¼ .126).
Cardiopulmonary bypass time was longer in the repeat
sternotomy group (88.0  45.7 minutes) in comparison to
the primary sternotomy group (66.5  25.1 minutes;
P < .001). But there was no difference in the aortic
crossclamp time in the repeat sternotomy group (51.1 
19.7 minutes) in comparison to the primary sternotomy
group (49.2  17.7 minutes; P¼ .282). Intra-aortic balloon
pump therapy was used in 15 patients (13.5%) in the repeat
sternotomy group and in 10 patients (1.9%) in the primary
sternotomy group (P<.001).
We report operative morbidity and mortality data in
Table 2. Stroke occurred in 3 patients (2.7%) following
repeat sternotomy and in 10 patients (1.9%) after primary
sternotomy (P ¼ .710). Rates of myocardial infarction,
renal failure, and reoperation for bleeding were similar
between the 2 groups. Operative mortality occurred in 7
patients (6.3%) in the repeat sternotomy group and in 19
patients (3.7%) in the primary sternotomy group
(P ¼ .196). The cause of death was cardiac-related in 16
patients (64.0%). In the repeat sternotomy group, 1 death
was related to a sternal reentry injury of the right ventricle
and left internal mammary artery bypass graft. There were1900 The Journal of Thoracic and Cardiovascular Surno operative deaths in the 7 patients who received either a
third (n ¼ 6) or fourth (n ¼ 1) sternotomy.
We report the results of univariate logistic regression of
variables predicting operative mortality in Table 3. The
only preoperative patient characteristics predictive of death
were ejection fraction (odds ratio [OR], 0.97; 95%
confidence interval [CI], 0.95-1.0; P ¼ .032) and previous
myocardial infarction (OR, 6.99; 95% CI, 1.47-49.45;
P ¼ .014). Repeat sternotomy was not predictive of
operative mortality in the univariate analysis (OR, 1.77;
95% CI, 0.68-4.14; P ¼ .387). Multivariate analysis
identified only previous myocardial infarction as being
predictive of operative mortality (OR, 5.63; 95% CI,
0.96-43.87; P ¼ .042).
DISCUSSION
The main finding in our study is that repeat sternotomy is
not a predictor of operative mortality for isolated surgical
aortic valve replacement. We evaluated 629 octogenarian
patients with aortic valve stenosis who underwent operation
for isolated surgical aortic valve replacement. Of those
patients, 111 (17.6%) required repeat sternotomy because
of a previous coronary artery bypass graft operation.
Patients who underwent a repeat sternotomy had greater
prevalence of preoperative comorbidity and higher STS
predicted risk of mortality scores. Despite the greater oper-
ative risk, the repeat sternotomy group experienced similar
operative mortality in comparison to patients who received
primary sternotomy (6.4% vs 3.7%; P ¼ .196).
The outcome of medical management in elderly patients
with symptomatic severe aortic is disappointing. Leon
and colleagues2 demonstrated a 1-year mortality rate of
49.7% with aggressive medical therapy in patients
(mean age, 83.2 years) with symptomatic severe aortic valve
stenosis. However, there is general agreement in the litera-
ture that such patients benefit from surgical aortic valve
replacement.6 For instance, Varadarajan and colleagues7 re-
ported 5-year survival of 68% in elderly patients (mean age,
85.3 years) treated with surgical aortic valve replacement in
comparison to 22% in patients (mean age, 83 years)
managed without operation (P< .001). And importantly,
Saxena and colleagues8 reported the 5-year survival of
male elderly patients (mean age, 83.4 years) undergoing
surgical aortic valve replacement at 65%, which is compa-
rable to the expected survival of age-matched Australian
men (mean age, 83 years) at 64.3%.
As a general finding, repeat sternotomy does not increase
the risk of operative mortality. LaPar and colleagues9
reported the outcome of 99 patients who underwent
operation from 2004 through 2007 with repeat sternotomy
for surgical aortic valve replacement. The group had
equivalent mortality to patients who underwent operation
for primary sternotomy (3.5% vs 2.0%; P ¼ .65).
Importantly, in this series, patients undergoing repeatgery c November 2014
TABLE 1. Society of Thoracic Surgeons (STS) defined patient characteristics
Characteristic Repeat sternotomy (n ¼ 111) Primary sternotomy (n ¼ 518) P value
Continuous variables Mean  standard deviation
Age, y 83.2  2.5 83.9  3.3 .214
Creatinine, mg/dL 1.4  0.8 1.2  0.5 .077
Ejection fraction,% 54.5  15.7 59.2  13.0 .003
STS predicted risk of mortality,% 8.6  5.6 5.6  3.9 <.001
Categorical variables n (%)
Male sex 89/111 (80.2) 233/518 (45.0) <.001
Diabetes 29/111 (26.1) 91/518 (17.6) .045
Chronic lung disease 99/111 (89.2) 414/518 (79.9) .022
Peripheral vascular disease 29/111 (26.1) 631/518 (12.2) <.001
Cerebrovascular disease 29/111 (26.1) 98/518 (18.9) .091
Previous myocardial infarction 34/64 (53.1) 45/224 (20.1) <.001
Previous percutaneous coronary intervention 32/85 (37.7) 42/322 (13.0) <.001
Previous coronary artery disease 111 (100) 71/518 (13.7) <.001
New York Heart Association functional class III-IV 87/111 (78.4) 342/518 (66.0) .013
Operative status urgent 6/111 (5.4) 46/518 (8.9) .260
TABLE 3. Univariate logistic regression of preoperative variables
predicting operative mortality
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operative risk; however, the mean age of the patients was
only 66.5 years. Similar results were also reported in a
study of 427 patients by Sundt and colleagues.3 They noted
no difference in 30-day mortality following repeat
sternotomy in comparison to primary sternotomy for
surgical aortic valve replacement (7.7% vs 6.3%;
P ¼ .763); but, mean age was 73.1 years.
There are limited data on the effect that repeat
sternotomy has on the outcome of surgical aortic valve
replacement in octogenarian patients. Melby, Langanay,
and colleagues4,5 reported operative mortality rates of
20% and 23.5%, respectively; but the number of
patients in each study was 25 or fewer. Vasquez and
colleagues6 published a meta-analysis of 9 studies with
data on 1981 octogenarian patients who received surgical
aortic valve replacement, among which there were patients
with a history of prior cardiac surgery. The pooled
proportion operative mortality was 6.6% (95% CI,
5.0-8.3). However, none of the 9 studies looked specifically
at the risk of repeat sternotomy for surgical aortic valveTABLE 2. Operative morbidity and mortality, by operation
Variable
Repeat
sternotomy,
n (%)
(n ¼ 111)
Primary
sternotomy,
n (%)
(n ¼ 518)
P
value
Mortality 7 (6.3) 19 (3.7) .196
Any complication 26 (23.4) 63 (12.2) .004
Intra-aortic balloon pump therapy 15 (13.5) 10 (1.93) <.001
Myocardial infarction 1 (1.0) 1 (0.2) .333
New pacemaker 2 (1.8) 15 (2.9) .750
Renal failure 7 (6.3) 20 (3.9) .298
Reoperation for bleeding 9 (8.1) 24 (4.6) .157
Stroke 3 (2.7) 10 (1.9) .710
The Journal of Thoracic and Carreplacement in patients with a history of coronary artery
bypass graft operation.
Surgical valve replacement appears to be equally safe as
transcatheter replacement. In the Placement of Aortic
Transcatheter Valve Trial, Smith and colleagues10
demonstrated no difference in 30-day operative mortality
rates in patients who received transcatheter replacement
versus surgical replacement (3.4% vs 6.5%; P ¼ .07). In
that study, 299 patients (42.8%) had a history of previous
coronary artery bypass graft operation and the mean age
of members of each of the 2 groups was greater than 80
years. An important point to note is that the risk of death
from any cause at 1 year was higher in patients in the
transcatheter replacement group (risk ratio, 1.35; 95%
CI, 0.88-2.08; P ¼ .02). Kodali and colleagues11 reported
a similar finding at 2 years of follow-up.
We noted no difference in the outcomes of stroke,
reoperation for bleeding, and renal failure with repeatVariable
Odds ratio
(95% confidence
interval)
P
value
Previous myocardial infarction 6.99 (1.47-49.54) .014
Left ventricle ejection fraction 0.97 (0.95-1.00) .032
Repeat sternotomy 1.77 (0.68-4.14) .230
Cerebral vascular disease 0.50 (0.12-1.58) .232
Age 1.07 (0.95-1.19) .279
Peripheral vascular disease 1.41 (0.46-3.57) .513
Operative status urgent 1.47 (0.34-4.43) .556
New York Heart Association functional
class III-IV
1.28 (0.55-3.32) .580
Diabetes 1.29 (0.50-3.28) .610
Creatinine 0.80 (0.20-1.76) .660
Gender, female 1.05 (0.48-2.33) .901
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patients who received repeat sternotomy experienced a
higher prevalence of intra-aortic balloon pump therapy
than those who received primary sternotomy (13.5% vs
1.9%; P<.001). It is controversial to compare the 2 groups
because the repeat sternotomy group had greater prevalence
of comorbidity (ie, coronary artery disease) and more than
1.5 times the STS predicted risk of operative mortality.
There are no studies in the literature with which to make a
direct comparison, and unfortunately, many studies do not
even report the data on intra-aortic balloon pump therapy.
We found 2 studies that provide some insight on
intra-aortic balloon pump therapy after repeat sternotomy
and surgical aortic valve replacement, but not necessarily
in octogenarian patients. Vohra and colleagues12 reported
on 104 patients (median age, 75 years; range, 37-90 years).
In that study, 8 patients (7.7%) required intra-aortic balloon
pump therapy. And Khaladj and colleagues13 reported on 34
patients (median age, 75 years; range, 60-84 years) of whom
2 patients (5%) received intra-aortic balloon pump therapy.
The results from these 2 studies are comparable to what we
report (ad hoc Fisher exact test comparison to our data:
Vohra study,12 P ¼ .123; and Khaladj study,13 P ¼ .185).
Our report has the inherent limitations of a retrospective
study that includes an 18-year study period and probable
significant selection bias. Fortunately, the majority of
patients in both study groups received operation during
the second half of the study period. Theoretically, patients
would have been exposed to the same time-related
biases with equal effect. The patients in our report were
operated on at a high-volume tertiary referral center and
were selected for operation by a group of surgeons well
versed in complex reoperative cardiac surgical procedures.
Importantly, the reported outcomes may not be reproducible
at centers without similar reoperative cardiac experience.
It is impossible to fully assess the selection bias, and
referral to a center with such experience is an option to be
considered in these patients.
CONCLUSIONS
Surgical aortic valve replacement can be done safely in
octogenarian patients with a previous coronary artery1902 The Journal of Thoracic and Cardiovascular Surbypass graft operation. Our experience is that the
prevalence of operative morbidity and mortality is the
same as for primary sternotomy and surgical aortic valve
replacement. Based on the available evidence, there is no
compelling argument to abandon the technique in favor of
transcatheter replacement. Repeat sternotomy for surgical
aortic valve replacement is a safe option.
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